SARS-CoV-2 Inhibitors from Nigella Sativa
Sign Up to like & getrecommendations! Published in 2022 at "Applied Biochemistry and Biotechnology"
DOI: 10.1007/s12010-021-03790-8
Abstract: The recently encountered severe acute respiratory syndrome coronavirus 2 creates huge predicaments among various countries. Lack of specific treatment of COVID-19 disease demands urgency in drug design against SARS-CoV-2 targets. Nigella sativa the miraculous herb… read more here.
Keywords: sars cov; inhibitors nigella; cov inhibitors; nigella sativa ... See more keywords
SARS-CoV-2 Inhibitors Identified by Phenotypic Analysis of a Collection of Viral RNA-Binding Molecules
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceuticals"
DOI: 10.3390/ph15121448
Abstract: Antiviral agents are needed for the treatment of SARS-CoV-2 infections and to control other coronavirus outbreaks that may occur in the future. Here we report the identification and characterization of RNA-binding compounds that inhibit SARS-CoV-2… read more here.
Keywords: rna binding; inhibitors identified; rna; cov inhibitors ... See more keywords
Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones
Sign Up to like & getrecommendations! Published in 2022 at "Viruses"
DOI: 10.3390/v14071458
Abstract: Despite the fast development of vaccines, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still circulating and generating variants of concern (VoC) that escape the humoral immune response. In this context, the search for anti-SARS-CoV-2… read more here.
Keywords: inhibitors isoflavone; cov inhibitors; flavonols better; isoflavone flavones ... See more keywords